Dr. Clay Siegall Recent Interview with Inspirery
Dr. Clay Siegall is the CEO and also the founder of a Seattle-based biotech company known as the Seattle Genetics. In the year 1998, the firm made a deal with developing therapy drug especially for those types of mortal diseases that have not seen any improvements for a long time. Dr. Siegall has a BS in Zoology from the University of Maryland. Dr. Clay also has a Ph.D. in Genetics which he got from George Washington University. He has been in the lead with his firm in coming up with the very first FDA-approved antibody treatment conjugate. The other thing is that Dr. Siegall has led the company in developing a pipeline of over twenty drugs as well as partnering with other manufacturers of drugs such as Pfizer, Bayer, and Genentech including others.
With the leadership of Dr. Clay Siegall, the Seattle Genetics has grown from just a small startup to a very powerful player in the space of cancer research. Dr. Siegall continues to add that he has a lot of plans ahead for this firm as there are several drugs in the pipeline and the potential indications for the drugs are in the increase. This places the firm in a better position in the industry of drug development. He believes that the ancient ways of treating cancer are in some days going to find a place in the dustbin. The therapies he says will be succeeded by new and more effective and tolerable targeted drugs being developed.
According to a recent interview, Dr. Clay Siegall started the firm due to his passion for medicine, technology and the need to restore people’s health especially those who are relegated to die. His first interest was in the treatment of cancer while he was in University of Maryland when one of his relatives got cancer and almost died as a result of chemotherapy. After he came to know that there were other forms of treatment, Dr. Clay put in his mind that there must be other better ways of dealing with these mortal diseases. He adds that money also contributed to him starting the business.